CA3230658A1 - Dispositif pour traiter un anevrisme d'un vaisseau sanguin - Google Patents
Dispositif pour traiter un anevrisme d'un vaisseau sanguin Download PDFInfo
- Publication number
- CA3230658A1 CA3230658A1 CA3230658A CA3230658A CA3230658A1 CA 3230658 A1 CA3230658 A1 CA 3230658A1 CA 3230658 A CA3230658 A CA 3230658A CA 3230658 A CA3230658 A CA 3230658A CA 3230658 A1 CA3230658 A1 CA 3230658A1
- Authority
- CA
- Canada
- Prior art keywords
- blood vessel
- vessel
- segment
- vessel member
- aorta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 665
- 206010002329 Aneurysm Diseases 0.000 title claims abstract description 228
- 238000011282 treatment Methods 0.000 title description 32
- 241000124008 Mammalia Species 0.000 abstract description 6
- 238000004891 communication Methods 0.000 description 442
- 210000001519 tissue Anatomy 0.000 description 296
- 210000000709 aorta Anatomy 0.000 description 259
- 239000012530 fluid Substances 0.000 description 202
- 238000000034 method Methods 0.000 description 169
- 238000004146 energy storage Methods 0.000 description 165
- 239000007943 implant Substances 0.000 description 144
- 230000006870 function Effects 0.000 description 96
- 230000005291 magnetic effect Effects 0.000 description 92
- 230000005540 biological transmission Effects 0.000 description 84
- 230000035807 sensation Effects 0.000 description 83
- 235000019615 sensations Nutrition 0.000 description 83
- 230000000638 stimulation Effects 0.000 description 78
- 238000012546 transfer Methods 0.000 description 77
- 210000001367 artery Anatomy 0.000 description 74
- 230000008878 coupling Effects 0.000 description 73
- 238000010168 coupling process Methods 0.000 description 73
- 238000005859 coupling reaction Methods 0.000 description 73
- 210000003205 muscle Anatomy 0.000 description 71
- 230000001276 controlling effect Effects 0.000 description 67
- 210000002376 aorta thoracic Anatomy 0.000 description 58
- 230000001965 increasing effect Effects 0.000 description 57
- 230000004044 response Effects 0.000 description 49
- 238000012795 verification Methods 0.000 description 49
- 239000000463 material Substances 0.000 description 44
- 230000006835 compression Effects 0.000 description 43
- 238000007906 compression Methods 0.000 description 43
- 230000017531 blood circulation Effects 0.000 description 38
- 238000005259 measurement Methods 0.000 description 37
- 230000033001 locomotion Effects 0.000 description 36
- 108091006146 Channels Proteins 0.000 description 34
- 210000002216 heart Anatomy 0.000 description 29
- 238000012545 processing Methods 0.000 description 29
- 230000008859 change Effects 0.000 description 28
- 210000003815 abdominal wall Anatomy 0.000 description 25
- 229910010293 ceramic material Inorganic materials 0.000 description 25
- 210000003195 fascia Anatomy 0.000 description 24
- 239000002861 polymer material Substances 0.000 description 23
- 239000010936 titanium Substances 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 22
- 238000012790 confirmation Methods 0.000 description 22
- 230000009471 action Effects 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 229910052751 metal Inorganic materials 0.000 description 21
- 239000002184 metal Substances 0.000 description 21
- 230000008093 supporting effect Effects 0.000 description 20
- 230000003287 optical effect Effects 0.000 description 19
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 18
- 229910052719 titanium Inorganic materials 0.000 description 18
- 230000036772 blood pressure Effects 0.000 description 17
- 210000000702 aorta abdominal Anatomy 0.000 description 16
- 230000006378 damage Effects 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 16
- 230000007246 mechanism Effects 0.000 description 15
- 230000003387 muscular Effects 0.000 description 15
- 230000002572 peristaltic effect Effects 0.000 description 15
- 239000004814 polyurethane Substances 0.000 description 15
- 210000004872 soft tissue Anatomy 0.000 description 15
- 210000001562 sternum Anatomy 0.000 description 15
- 230000009278 visceral effect Effects 0.000 description 15
- 239000004020 conductor Substances 0.000 description 14
- 239000013013 elastic material Substances 0.000 description 14
- 230000036541 health Effects 0.000 description 14
- 229920001296 polysiloxane Polymers 0.000 description 14
- 230000001131 transforming effect Effects 0.000 description 14
- 230000003187 abdominal effect Effects 0.000 description 13
- 230000036982 action potential Effects 0.000 description 13
- 230000004913 activation Effects 0.000 description 13
- 210000000038 chest Anatomy 0.000 description 13
- 230000035487 diastolic blood pressure Effects 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- 210000000988 bone and bone Anatomy 0.000 description 12
- 210000001168 carotid artery common Anatomy 0.000 description 12
- 230000007423 decrease Effects 0.000 description 12
- 210000000056 organ Anatomy 0.000 description 12
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 12
- 239000004810 polytetrafluoroethylene Substances 0.000 description 12
- 229920002635 polyurethane Polymers 0.000 description 12
- 230000007958 sleep Effects 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- 210000000683 abdominal cavity Anatomy 0.000 description 11
- 230000004888 barrier function Effects 0.000 description 11
- 230000003247 decreasing effect Effects 0.000 description 11
- 238000006073 displacement reaction Methods 0.000 description 11
- 210000000663 muscle cell Anatomy 0.000 description 11
- 210000003270 subclavian artery Anatomy 0.000 description 11
- 210000004304 subcutaneous tissue Anatomy 0.000 description 11
- 210000001015 abdomen Anatomy 0.000 description 10
- 239000003990 capacitor Substances 0.000 description 10
- 208000028867 ischemia Diseases 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 210000004379 membrane Anatomy 0.000 description 10
- 210000005036 nerve Anatomy 0.000 description 10
- 238000006213 oxygenation reaction Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 238000007789 sealing Methods 0.000 description 10
- 230000035488 systolic blood pressure Effects 0.000 description 10
- 230000007774 longterm Effects 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000005265 energy consumption Methods 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 206010033675 panniculitis Diseases 0.000 description 8
- 210000004303 peritoneum Anatomy 0.000 description 8
- 239000012858 resilient material Substances 0.000 description 8
- 230000009885 systemic effect Effects 0.000 description 8
- 238000002604 ultrasonography Methods 0.000 description 8
- 210000003484 anatomy Anatomy 0.000 description 7
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 7
- 239000003989 dielectric material Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 238000007912 intraperitoneal administration Methods 0.000 description 7
- 210000000614 rib Anatomy 0.000 description 7
- 230000004936 stimulating effect Effects 0.000 description 7
- 210000000707 wrist Anatomy 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000002808 connective tissue Anatomy 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 230000003601 intercostal effect Effects 0.000 description 6
- 239000007769 metal material Substances 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 230000001936 parietal effect Effects 0.000 description 6
- 230000001830 phrenic effect Effects 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 238000005086 pumping Methods 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 210000003050 axon Anatomy 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 210000001710 bronchial artery Anatomy 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000002710 gonadal effect Effects 0.000 description 5
- 210000003090 iliac artery Anatomy 0.000 description 5
- 230000000977 initiatory effect Effects 0.000 description 5
- 238000009434 installation Methods 0.000 description 5
- 230000001788 irregular Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000001699 lower leg Anatomy 0.000 description 5
- 230000017074 necrotic cell death Effects 0.000 description 5
- 239000002858 neurotransmitter agent Substances 0.000 description 5
- 210000002254 renal artery Anatomy 0.000 description 5
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- -1 Peek Polymers 0.000 description 4
- 210000003489 abdominal muscle Anatomy 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 230000005294 ferromagnetic effect Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000003176 fibrotic effect Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 230000000399 orthopedic effect Effects 0.000 description 4
- 210000000505 parietal peritoneum Anatomy 0.000 description 4
- 210000004197 pelvis Anatomy 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 239000002210 silicon-based material Substances 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 230000009747 swallowing Effects 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920002943 EPDM rubber Polymers 0.000 description 3
- 244000043261 Hevea brasiliensis Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229920000459 Nitrile rubber Polymers 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 229920000249 biocompatible polymer Polymers 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000009172 bursting Effects 0.000 description 3
- 239000004917 carbon fiber Substances 0.000 description 3
- 239000003575 carbonaceous material Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000008867 communication pathway Effects 0.000 description 3
- 230000001054 cortical effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000000569 greater omentum Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229920002681 hypalon Polymers 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000000565 lesser omentum Anatomy 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 229920002529 medical grade silicone Polymers 0.000 description 3
- 210000003975 mesenteric artery Anatomy 0.000 description 3
- 210000004249 mesenteric artery inferior Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000004118 muscle contraction Effects 0.000 description 3
- 210000004457 myocytus nodalis Anatomy 0.000 description 3
- 229920003052 natural elastomer Polymers 0.000 description 3
- 229920001194 natural rubber Polymers 0.000 description 3
- 239000010955 niobium Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920003225 polyurethane elastomer Polymers 0.000 description 3
- 230000010349 pulsation Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 210000002363 skeletal muscle cell Anatomy 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- MFRCZYUUKMFJQJ-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;1,3-dioxan-2-one Chemical group O=C1OCCCO1.O=C1COC(=O)CO1 MFRCZYUUKMFJQJ-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 229920000049 Carbon (fiber) Polymers 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 101100234002 Drosophila melanogaster Shal gene Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 240000006829 Ficus sundaica Species 0.000 description 2
- 230000005355 Hall effect Effects 0.000 description 2
- 244000035744 Hura crepitans Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 244000166071 Shorea robusta Species 0.000 description 2
- 235000015076 Shorea robusta Nutrition 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229920010741 Ultra High Molecular Weight Polyethylene (UHMWPE) Polymers 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- 229910026551 ZrC Inorganic materials 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- OTCHGXYCWNXDOA-UHFFFAOYSA-N [C].[Zr] Chemical compound [C].[Zr] OTCHGXYCWNXDOA-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000010351 charge transfer process Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 230000037020 contractile activity Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000002767 hepatic artery Anatomy 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 210000001363 mesenteric artery superior Anatomy 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229910052758 niobium Inorganic materials 0.000 description 2
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 210000001139 rectus abdominis Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 2
- 229910010271 silicon carbide Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000003393 splenic effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000002381 testicular Effects 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- UONOETXJSWQNOL-UHFFFAOYSA-N tungsten carbide Chemical compound [W+]#[C-] UONOETXJSWQNOL-UHFFFAOYSA-N 0.000 description 2
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000002585 Contractile Proteins Human genes 0.000 description 1
- 108010068426 Contractile Proteins Proteins 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010053172 Fatal outcomes Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108091005975 Myofilaments Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 108010052164 Sodium Channels Proteins 0.000 description 1
- 102000018674 Sodium Channels Human genes 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 210000002453 autonomic neuron Anatomy 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229920001746 electroactive polymer Polymers 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000012199 graphalloy Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000012784 inorganic fiber Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 239000002557 mineral fiber Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005591 polysilicon Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 210000000063 presynaptic terminal Anatomy 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000036279 refractory period Effects 0.000 description 1
- 230000036390 resting membrane potential Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000037152 sensory function Effects 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 102000027509 sensory receptors Human genes 0.000 description 1
- 108091008691 sensory receptors Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002151 serous membrane Anatomy 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002504 synaptic vesicle Anatomy 0.000 description 1
- 229910001936 tantalum oxide Inorganic materials 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00221—Electrical control of surgical instruments with wireless transmission of data, e.g. by infrared radiation or radiowaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
- A61B2017/00557—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00681—Aspects not otherwise provided for
- A61B2017/00734—Aspects not otherwise provided for battery operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00889—Material properties antimicrobial, disinfectant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
- A61B2090/065—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring contact or contact pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
- A61B5/02014—Determining aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/061—Blood vessels provided with means for allowing access to secondary lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
Selon un premier aspect, l'invention concerne un dispositif pour traiter un anévrisme d'un vaisseau sanguin d'un patient mammifère. Le dispositif comprend un élément implantable actionnable conçu pour être placé en liaison avec le vaisseau sanguin ayant l'anévrisme. L'élément implantable est conçu pour entourer partiellement la circonférence de l'anévrisme de sorte qu'au moins une ramification provenant du vaisseau n'est pas enfermée par l'élément implantable.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP2021/073893 | 2021-08-30 | ||
PCT/EP2021/073893 WO2022043555A1 (fr) | 2020-08-31 | 2021-08-30 | Fourniture d'énergie à distance à un implant comprenant un condensateur pour fournir les rafales d'énergie nécessaire aux parties de l'implant consommant de l'énergie |
PCT/EP2022/073773 WO2023031036A1 (fr) | 2021-08-30 | 2022-08-26 | Dispositif pour traiter un anévrisme d'un vaisseau sanguin |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3230658A1 true CA3230658A1 (fr) | 2023-03-09 |
Family
ID=83193259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3230658A Pending CA3230658A1 (fr) | 2021-08-30 | 2022-08-26 | Dispositif pour traiter un anevrisme d'un vaisseau sanguin |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2022340836A1 (fr) |
CA (1) | CA3230658A1 (fr) |
WO (1) | WO2023031036A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117045303B (zh) * | 2023-08-16 | 2024-02-02 | 南京思脉德医疗科技有限公司 | 一种栓塞弹簧圈输送系统的换丝装置 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0817870B8 (pt) * | 2007-10-11 | 2021-06-22 | Implantica Patent Ltd | dispositivo para tratamento de aneurisma |
US8702776B2 (en) * | 2010-04-26 | 2014-04-22 | Paul Heltai | Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system |
EP3849468A4 (fr) * | 2018-09-12 | 2022-05-25 | Endologix LLC | Systèmes et procédés de greffe d'endoprothèse ayant une structure de remplissage gonflable et un manchon inclinable |
-
2022
- 2022-08-26 CA CA3230658A patent/CA3230658A1/fr active Pending
- 2022-08-26 WO PCT/EP2022/073773 patent/WO2023031036A1/fr active Application Filing
- 2022-08-26 AU AU2022340836A patent/AU2022340836A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2023031036A1 (fr) | 2023-03-09 |
AU2022340836A1 (en) | 2024-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3230658A1 (fr) | Dispositif pour traiter un anevrisme d'un vaisseau sanguin | |
AU2022340838A1 (en) | Implantable urethra restriction device | |
WO2023031045A1 (fr) | Dispositif de restriction | |
EP4395703A1 (fr) | Dispositif pour traiter un anévrisme d'un vaisseau sanguin | |
US20230065828A1 (en) | Restriction device | |
US20230067834A1 (en) | Implantable urethra restriction device | |
US20230067764A1 (en) | Treatment of gerd | |
US20230062862A1 (en) | Treatment of gerd | |
EP4395700A1 (fr) | Dispositif de restriction d'urètre implantable | |
AU2022338977A1 (en) | Restriction device | |
EP4395699A1 (fr) | Dispositif de restriction | |
CA3230660A1 (fr) | Appareil et procede permettant d'obtenir un controle urinaire | |
WO2023031032A1 (fr) | Appareil et procédé permettant d'obtenir un contrôle urinaire | |
EP4395704A1 (fr) | Appareil et procédé permettant d'obtenir un contrôle urinaire | |
WO2023031039A1 (fr) | Dispositif d'étirage | |
WO2024041758A1 (fr) | Pompe hydraulique ou pneumatique implantable | |
AU2022338025A1 (en) | Stretching device | |
EP4395718A1 (fr) | Dispositif d'étirage | |
WO2023156529A1 (fr) | Dispositif d'étirage | |
WO2023156574A1 (fr) | Appareil et procédé pour obtenir un contrôle urinaire | |
CA3230540A1 (fr) | Dispositif medical excite implantable, procedes et kit associes | |
CA3225646A1 (fr) | Traitement d'une maladie de reflux gastro-oesophagien | |
EP4395717A1 (fr) | Dispositif d'étirage | |
CA3228110A1 (fr) | Dispositif de restriction | |
CA3233737A1 (fr) | Traitement de l'hypertension |